iMedOptions

iMedOptions, LLC, operating primarily as Clinical Care Options (CCO), is a prominent medical education and communications company specializing in continuing medical education (CME) for healthcare professionals. Founded in 2001, the company is recognized for its expertise in high-science therapeutic areas, including infectious diseases (HIV and hepatitis), oncology, and hematology. iMedOptions develops and delivers evidence-based educational programs, clinical decision support tools, and interactive digital resources designed to improve patient care and clinical outcomes. In 2019, the company was acquired by Huntsworth and now functions as a key component of the Inizio group, providing global medical communications services to the pharmaceutical and healthcare industries.